Contralateral suppression in adrenal venous sampling predicts clinical and biochemical outcome in primary aldosteronism
Jessica Okubo, Paula Frudit, Aline C B S Cavalcante, Ana A W Maciel, Thais C Freitas, Bruna Pilan, Gustavo F C Fagundes, Nara L Queiroz, Matheo A M Stumpf, Victor C M Souza, Eduardo Z Kawahara, Tatiana S Goldbaum, Maria Adelaide A Pereira, Vinicius F Calsavara, Fernando M A Coelho, Vitor Srougi, Fabio Y Tanno, Jose L Chambo, Luiz A Bortolotto, Luciano F Drager, Maria Candida B V Fragoso, Ana Claudia Latronico, Berenice B Mendonca, Francisco C Carnevale, Madson Q Almeida- Biochemistry (medical)
- Clinical Biochemistry
- Endocrinology
- Biochemistry
- Endocrinology, Diabetes and Metabolism
Abstract
Context
The role for hormone parameters at adrenal venous sampling (AVS) in predicting clinical and biochemical outcome remains controversial.
Objective
To investigate the impact of hormone parameters at AVS under cosyntropin stimulation on lateralization and on complete biochemical and clinical outcome.
Methods
We retrospectively evaluated 150 sequential AVS under cosyntropin infusion. Bilateral successful cannulation rate was 83.3% (n = 140), 47.9% bilateral and 52.1% unilateral. The lateralization index (LI), aldosterone/cortisol ratio (A/C) in the dominant adrenal vein (AV), relative aldosterone secretion index (RASI = A/C in AV divided by A/C in inferior vena cava) were assessed. The contralateral suppression (CS) percentage was defined by (1 – nondominant RASI) *100.
Results
A nondominant RASI <0.5 (CS >50%) had 86.84% sensitivity and 92.96% specificity to predict contralateral lateralization. An A/C ratio in dominant AV >5.9 (74.67% sensitivity and 80% specificity) and dominant RASI >4.7 (35.21% sensitivity and 88.06% specificity) had a worst performance to predict ipsilateral lateralization. Complete biochemical and clinical cure were significantly more frequent in the patients with CS >50% [98.41% vs. 42.86% (p < 0.001) and 41.94% vs. 0% (p < 0.001)]. CS correlated with high aldosterone at diagnosis (p < 0.001) and low postoperative aldosterone levels at 1 month (p = 0.019). Postoperative biochemical hypoaldosteronism was more frequent in patients with CS >50% (70% vs. 16.67%, p = 0.014). In multivariable analysis, a CS >50% was associated with complete biochemical cure (OR 125, 95%CI 11.904–5,000; p = 0.001) and hypertension remission (OR 12.19, 95%CI 2.074–250; p = 0.023).
Conclusion
A CS >50% was an independent predictor of complete clinical and biochemical cure. Moreover, it can predict unilateral PA and postoperative biochemical hypoaldosteronism. Our findings underscore the usefulness of CS for clinical decision-making.